Research lines of Ischaemic Heart Disease

Reading time: 1 min

Research into Ischaemic heart disease seeks to prevent the disease’s progression, and improve treatment and patient prognosis. 

  • In attempts to retard the evolution of the disease, studies have been designed with medicines that can alter HDL and LDL cholesterol levels (good and bad cholesterol, respectively) or improve the management and control of diabetes and high blood pressure
  • To improve treatment outcomes, studies have been conducted with new devices that can be used without “opening the chest”, such as fully biodegradable stents, which could represent a revolutionary advance in the next few years.
  • Similarly, researchers are investigating the possibility of using cell therapy (stem cells) to regenerate the dead portion of heart muscle caused by an infarction. The results of these studies are expected to be published in the next 3–5 years.

Substantiated information by:

Manel Sabaté Tenas
Marta Farrero Torres

Published: 20 February 2018
Updated: 20 February 2018

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.